
Ripadep Plus 0.5mg/500mg Tablet
Marketer
Globus Labs
Salt Composition
Repaglinide (0.5mg) + Metformin (500mg)
Overview Ripadep Plus 0.5mg/500mg Tablet
Diabexe Duo 0.5mg/500mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Administer Diabexe Duo with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. This medication is part of a comprehensive diabetes management plan, incorporating diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Recognize these symptoms and carry a fast-acting glucose source (e.g., sugary foods, juice). Alcohol consumption increases hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Disclose any history of heart disease to your physician before commencing treatment. Pregnant or breastfeeding individuals require medical consultation prior to use. Regular blood sugar monitoring, along with blood tests to assess blood cell counts and liver function, are recommended by your doctor.
Uses of Ripadep Plus 0.5mg/500mg Tablet
Managing type 2 diabetes
Major Benefits of Ripadep Plus 0.5mg/500mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. It is recommended to take the Ripadep Plus 0.5mg/500mg tablet with a meal.
Common Side effects of Ripadep Plus 0.5mg/500mg Tablet:
- Hypoglycemia (low blood glucose level)
- Sweating
- Dizziness
- Diarrhea
- Loss of appetite
- Nausea
- Stomach pain
- Taste change
- Weight gain
How to use Ripadep Plus 0.5mg/500mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Ripadep Plus 0.5mg/500mg tablets should be administered with a meal.
How Ripadep Plus 0.5mg/500mg Tablet works:
The combined antidiabetic medication Ripadep Plus, available in 0.5mg/500mg tablets, contains two active pharmaceutical ingredients.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Ripadep Plus 0.5mg/500mg Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Ripadep Plus 0.5mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers before prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Ripadep Plus 0.5mg/500mg tablets safely. Available human data indicates minimal risk to the infant.
DrivingCAUTION
Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Ripadep Plus 0.5mg/500mg tablets, potentially requiring dosage modification. A physician's consultation is recommended. The medication is contraindicated in patients with severe kidney disease. Consistent monitoring of renal function is advised during treatment.
LiverCAUTION
For individuals with liver impairment, the use of Ripadep Plus 0.5mg/500mg tablets requires careful monitoring. Dosage modification may be necessary. A physician's consultation is advised. In patients experiencing mild to moderate liver disease, treatment typically commences with a reduced Ripadep Plus 0.5mg/500mg tablet dosage; however, its administration is contraindicated in cases of severe hepatic dysfunction.
What if you forget to take Ripadep Plus 0.5mg/500mg Tablet :
NA
Facts to Know About Ripadep Plus 0.5mg/500mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
